Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

NCT00275054 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

825

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Rituximab

Sponsor

German CLL Study Group